Innovative strategies for the elimination of viral hepatitis at a national level: a country case series.

Innovative strategies for the elimination of viral hepatitis at a national level: a country case series.

Schroeder, E Sophia;Pedrana, Alisa;Scott, Nick;Wilson, David;Kuschel, Christian;Aufegger, Lisa;Atun, Rifat;Baptista-Leite, Ricardo;Butsashvili, Maia;El-Sayed, Manal;Getahun, Aneley;Hamid, Saeed;Hammad, Radi;'t Hoen, Ellen;Hutchinson, Sharon J;Lazarus, Jeffrey V;Lesi, Olufunmilayo;Li, Wangsheng;Mohamed, Rosmawati Binti;Olafsson, Sigurdur;Peck, Raquel;Sohn, Annette H;Sonderup, Mark;Spearman, C Wendy;Swan, Tracy;Thursz, Mark;Walker, Tim;Hellard, Margaret;Howell, Jessica;
liver international : official journal of the international association for the study of the liver 2019
253
schroeder2019innovativeliver

Abstract

Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (1) evidence-gathering and planning; (2) implementation; and (3) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment, and implementation strategies for other countries facing similar challenges and resource constraints. This article is protected by copyright. All rights reserved.

Citation

ID: 17109
Ref Key: schroeder2019innovativeliver
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
17109
Unique Identifier:
10.1111/liv.14222
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet